SlideShare a Scribd company logo
The Role of PPIs in
Upper Gastrointestinal Bleeding;
Which one is The Best?
Mangatas SM Manalu
Internal Medicine Department
Mayapada Hospital – South Jakarta
Definitions
• Upper GI bleed – arising
from the esophagus,
stomach, or proximal
duodenum
• Mid-intestinal bleed –
arising from distal
duodenum to ileocecal
valve
• Lower intestinal bleed –
arising from colon/rectum
 Upper GI Tract
◦ Proximal to the Ligament of Treitz
◦ 65 - 70% of GI Bleeds
 Mid Intestinal GI Tract
2-3 % of GI Bleeds
 Lower GI Tract
◦ Distal to the Ligament of Treitz
◦ 25 -30% of GI Bleeds
Differential Diagnosis of
Upper GI bleeding
Esophageal varices
Gastric varices
Erosive gastritis
Mallory Weiss tear
Reflux esophagitis
Gastric malignancy
Vascular malformations
Nose bleed
Aorto-enteric fistula
Gastric ulcer
Duodenal ulcer
Consider the following
Tabel 1. Penyebab Tersering Perdarahan SCBA
pada Pasien yang menjalani Endoskopi
di Pusat Endoskopi RSCM selama tahun 2001-2005
Konsensus Nasional Perdarahan Saluran Cerna Bagian Atas, PB-PGI, 2012
 Initial Assessment and Resuscitation
 History and Physical Examination
 Assessment of the bleeding source
 Differential Diagnosis
 Investigations
 Management
◦ Conservative
◦ Therapeutic
 Airway, Breathing and Circulation
 Vital Signs:
◦ Pulse, BP, Temperature, Respiratory
Rate
 Fluid and Resuscitation Plan
◦ Co-morbidities
 RR, HR, and BP can be used to estimate
degree of blood loss/hypovolaemia
Class I Class II Class III Class IV
Volume Loss
(ml)
0-750 750-1500 1500-2000 >2000
Loss (%) 0-15 15-30 30-40 >40
RR 14-20 20-30 30-40 >40
HR <100 >100 >120 >140
BP Unchanged Unchanged Reduced Reduced
Urine Output
(ml/hr)
>30 20-30 5-15 Anuric
Mental State Restless Anxious Anxious/conf
used
Confused/
lethargic
 Confirm the GI Bleed - Hemoptysis or
Hemetemesis ???
 Manner of Presentation of a GI Bleed
◦ Hemetemesis
◦ Malena
◦ Hematochezia
◦ Occult Blood loss
◦ Symptoms of Blood loss
 Is it only the GI Bleed ??
 Assessment of the bleed
◦ Dizziness, Syncope, Chest Pain, SOB
Bleeding etiology Leading History
Mallory -Weiss tear Multiple Emesis before hematemesis, alcoholism
Esophageal ulcer Dysphagia, Odynophagia, GERD,
Peptic ulcer Epigastric pain, NSAID or aspirin use
Stress gastritis Patient in an ICU, gastrointestinal bleeding occurring
after admission, respiratory failure, multiorgan failure
Varices, portal
gastropathy
Alcoholism, Cirrhosis
Gastric antral
vascular ectasia
Renal failure, cirrhosis
Malignancy Recent involuntary weight loss, dysphagia, cachexia,
early satiety
Angiodysplasia Chronic renal failure, hereditary hemorrhagic
telangiectasia
Aortoenteric fistula Known aortic aneurysm, prior abdominal aortic
aneurysm repair
 Anticoagulation (warfarin/heparin)
 Use of Drugs NSAIDs,Steroids,Bisphosphonates
 Similar episodes before
 H/o Jaundice in past
 H/o Abdominal Surgery
 H/o Alcoholism
 H/o Smoking or Tobacco abuse
 H/o Cocaine abuse
 Pt’s Consciousness, Orientation
 Pallor, Icterus, Clubbing, Pedal
Edema
 Lymphadenopathy, JVP
 Signs of Liver Failure
 Systemic Examination
◦ Abdomen, CVS, RS, CNS
 Alopecia, Pallor, Icterus, Fetor Hepaticus,
Glossitis, Parotid Swelling
 Leukonychia, Clubbing, Palmar Erythema,
Dupuytren’s Contracture, Asterexis
 Loss of Axillary hair, Spider naevi,
Gynaecomastia,
 Ascites, Splenomegaly, Caput Medusae
 Testicular Atrophy, Loss of Pubic Hair
 Pedal Edema
Stool color and origin/pace of bleeding
• Guaiac positive stool
– Occult blood in stool
– Does not provide any localizing information
– Indicates slow pace, usually low volume bleeding
• Melena
– Very dark, tarry, pungent stool
– Usually suggestive of UGI origin (but can be small
intestinal, proximal colon origin if slow pace)
• Hematochezia
– Spectrum: bright red blood, dark red, maroon
– Usually suggestive of colonic origin (but can be UGI origin
if brisk pace/large volume)
 Major causes
 Peptic ulcer disease
 Esophageal and gastric varices
 Hemorrhagic gastritis
 Esophagitis
 Duodenitis
 Mallory-Weiss tear
 Angiodysplasia
 Upper gastrointestinal malignancy
 Anastomotic ulcers (after bariatric surgery)
 Dieulafoy lesion
 Minor causes
 Gastric antral vascular ectasia (watermelon
stomach)
 Portal hypertensive gastropathy
 Gastric polyps
 Aortoenteric fistula
 Connective tissue disease
 Postprocedural: nasogastric tube erosions,
endoscopic biopsy, endoscopic polypectomy,
endoscopic sphincterotomy
 Complete Blood count, ESR,
 Liver and Renal Function Tests, Electrolytes
 Prothrombin Time and INR
 BUN / Creatinine – ratio > 30 sensitivity of
68% and a specificity of 98%
 Stool Occult Blood Test
 Grouping and Cross Matching
 ECG, Cardiac enzymes(if essential)
 HIV, HbsAg, AntiHCV Markers
 ABC’s
 Fluid Resucitation
 NG Tube insertion and Lavage
 Hemodynamically Unstable – Hypotension,
Tachycardia, Postural Changes Urgent
Endoscopy
 Hemodynamically Stable  Plan Early
Endoscopy
 Tranexamic Acid I.V (+ Vit K in Liver Cirrochis)
 IV PPI Therapy
 A grossly bloody aspirate in the atraumatic NG insertion
CONFIRMS a UGI Bleed
 The type of bleed
 Red blood - active bleeding
 Coffee ground - recently active bleeding.
 Continued aspiration of red blood - severe, active
hemorrhage.
 Clears the field for endoscopic visualization
 Prevent aspiration of gastric content
 However, lavage may not be positive if bleeding has
ceased or arises beyond a closed pylorus.
An algorithm in the management of acute nonvariceal GI bleeding
Acute upper GI bleeding
Initial resuscitation, airway, volume restoration, nasogastric tube,
empiric high-dose PPI, risk stratification using clinical factors
Signs of on-going bleeding; such as shock
and fresh hematemesis or hematochezia
Urgent endoscopy
Stable patient
Endoscopy next morning
Epinephrine injection + Thermocoagulation to
actively bleeding ulcers and ulcers with NBW
Clots elevated and treatment to underlying vessel
Bleeding stopped
Unable to control bleeding, access
or localize bleeding point in the
presence of massive bleeding.
Second re-bleed
Consider
early discharge
Low-risk ulcers; flat
pigments and clean base
Treatment in Harisson’s PIM (18 th ed-2012)
1. Laine L. Gastrointestinal Bleeding. In Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrisons Princ Intern Med.
18th ed. New York: The McGraw-Hill Companies; 2012.
 Age > 60 yrs
 Comorbidities (Renal failure, Liver failure, CHF,
Malignancy)
 Variceal bleeding (as compared with nonvariceal
bleeding)
 Shock or hypotension on presentation
 Increasing number of units of blood transfused
 Active bleeding on Endoscopy
 Bleeding Ulcer of >2cm or a Spurting vessel
 Need for emergency surgery
TEST IQ
BAGAIMANA CARA
MEMBEDAKAN MANA YANG
SELEBRITIS dan
YANG BUKAN SELEBRITIS
(sok selebritis)
Dari foto ini???
JAWAB:
YANG SELEBRITIS TAHU BETUL
DI MANA LETAK KAMERA, MELIHAT KE
ARAH KAMERA SAAT DIFOTO KARENA
SUDAH BIASA BERPOSE, sedangkan
Yang SOK SELEBRITIS TIDAK TAHU
LETAK KAMERA “JULING”.......
LOL...!!...!!....!!!....
We Are Focusing on
Non Variceal
UGI’s Bleeding
Oesophagitis Angiodysplasia
 Gastric Carcinoma
• PPI Infusion
 IV Omeperazole 80mg bolus then 8mg/hr infusion or
Esomeprasole 40 mg bolus then 4 mg/hr infusion
• Endoscopic Therapy
 Bipolar Coagulation, Heater Probe, Injection
Therapy(Absolute Alcohol, 1:10,000 epinephrine),
Hemoclips
 Medical Management  After Acute Phase
◦ Antacids, H2 receptor Antagonists, oral PPIs,
◦ Cytoprotective Agents - Bismuth Preparations, Prostaglandin
Analogues
◦ H.Pylori Eradication
 Surgical Management
◦ Duodenal Ulcer
◦ Gastric Ulcer
Ann Intern Med. 2010;152:101-113.
Peran dari obat penekan asam
lambung
• Terapi farmakologis menggunakan obat yang mampu
menekan sekresi asam lambung merupakan pilihan yang
paling banyak digunakan sebagai standar pengobatan untuk
kasus perdarahan. Termasuk didalamnya untuk pencegahan
perdarahan ulang 1-5
• Tujuan terapi pada pasien tersebut adalah mencapai pH
dalam lambung (intragastric) diatas 6, sebuah kondisi dimana
proses pembentukan bekuan darah dapat stabil 1,6-7
1. Lin H-J, et al. Arch Intern Med 1998; 158: 54-8. 2. Lau JWY, et al. N Eng J Med 2000; 343: 310-6. 3. Liontiadis
GI, et al. Aliment Pharmacol ther 2005; 22: 169-74. 4. Sung JJ, et al. Ann Intern Med 2003; 139: 237-43. 5.
Barkun A, et al. Gastroenterology 2004; 126: A78 (Abstract). 6. Vorder Bruegge WF, et al. J Clin Gastroenterol
1990; 12: (Suppl 2): S35-40. 7. van Resburg, et al. Am J Gastroenterol 2003; 98: 2635-41
Tingkatan pH lambung yang disarankan pada
berbagai kasus penyakit asam lambung
pH lambung Indikasi
3.5
Penurunan kejadian perdarahan karena
stress mukosa lambung
4.5
Pepsin tidak aktif sebagai faktor agresif
mukosa lambung
=5 99.9% netralisasi asam
< 6
Pencegahan koagulasi dan aggregrasi
platelet darah
 6 Penurunan kejadian perdarahan ulang
8 Penghancuran pepsin
Stress-
Related
Mucosal
Disease
Prevention
of Ulcer
Rebleeding
Adapted from Vorder Bruegge WF, et al. J Clin Gastroenterol. 1990;12:S35–S40.
Stress Related Mucosal Disease perlu
pH>3.5
pH lambung Indikasi
3.5
Penurunan kejadian perdarahan karena
stress mukosa lambung
4.5
Pepsin tidak aktif sebagai faktor agresif
mukosa lambung
=5 99.9% netralisasi asam
< 6
Pencegahan koagulasi dan aggregrasi
platelet darah
 6 Penurunan kejadian perdarahan ulang
8 Penghancuran pepsin
Stress-
Related
Mucosal
Disease
Prevention
of Ulcer
Rebleeding
Adapted from Vorder Bruegge WF, et al. J Clin Gastroenterol. 1990;12:S35–S40.
• Stress-related mucosal disease
(SRMD) merupakan kondisi
berkesinambungan dari
kerusakan mukosa (superficial
mucosal damage) hingga
stress ulcer (focal deep
mucosal damage).
• Disebabkan iskemi mukosa,
SRMD biasanya dilihat pada
pasien yang dirawat di
Intensive Care Unit (ICU).
Stress-related mucosal disease dan
pH>3
Multiple ulcers of the stomach, occurring in a
chronically debilitated patient.
Stress Ulcers & Non Stress Ulcers –
perbedaan patofisiologi
Stress ulcer Non-stress ulcer (PUD)
• Multiple
• Acid/pepsin secretory mucosa
• Lack of chronic inflammation
• Asymptomatic (mostly!)
• Usually solitary
• Distal stomach/duodenum
• Chronic inflammation
• Symptomatic
Faktor Risiko perdarahan lambung karena
Stress Ulcer
• Respiratory failure
• Coagulopathy
• Increased risk with increased
severity of illness
• Multiple trauma
• Age >65
• Corticosteroids
• Prolonged NG tube placement
• NSAIDs
• Major surgery
• Respiratory failure
• Renal failure
• Acute hepatic failure
• Multiple organ failure
• Alcoholism
• Increase IgA antibody to HP
• Head injury
• Sepsis
• Burns >30–35% BSA
Curr Med Res Opin. 2005;21(1):11-18.
Terapi pada kasus Stress Ulcer
Curr Med Res Opin. 2005 Jan;21(1):11–18.
• Current preventative treatment strategies
o Histamine 2 receptor antagonists (H2RAs) – Suppressing acid secretion
o Proton pump inhibitors (PPIs) - Suppressing acid secretion
o Sucralfate - provides a protective barrier against acid in the GI tract.
• In the past, H2RAs have been preferentially used over PPIs-available in liquid
and intravenous formulations.
• Currently, PPI are preferable-availability of suspension and IV formulations.
Penelitian membuktikan bahwa PPI memberikan efikasi yang
lebih baik pada pencegahan stress Ulcer dibandingkan H2RA
pH>6 dibutuhkan untuk pencegahan
perdarahan berulang
pH lambung Indikasi
3.5
Penurunan kejadian perdarahan karena
stress mukosa lambung
4.5
Pepsin tidak aktif sebagai faktor agresif
mukosa lambung
=5 99.9% netralisasi asam
< 6
Pencegahan koagulasi dan aggregrasi
platelet darah
 6 Penurunan kejadian perdarahan ulang
8 Penghancuran pepsin
Stress-
Related
Mucosal
Disease
Prevention
of Ulcer
Rebleeding
Adapted from Vorder Bruegge WF, et al. J Clin Gastroenterol. 1990;12:S35–S40.
pH intragastric >=6
dibutuhkan untuk
mencegah disagregasi
platelet pada kasus
perdarahan
gastrointestinal yang
diebabkan oleh ulkus
Target pH intragastrik pada
kasus perdarahan ulkus
peptikum
Green FW, et al. Gastroenterology 1978;74:38–43
Proton Pump InhibitorspH up to 6
Efektivitas PPI dalam
menurunkan kejadian
perdarahan berulang pada
pasien dengan perdarahan non
variceal
Barkun AN, et al. Ann Intern Med. 2010;152:101-113
Percentage of time pH>6 during first 3 hours
with esomeprazole iv (healthy volunteers)
0
20
40
60
80
100
Mean fraction of first 3 hours (%)
*p<0.05 versus 80 mg + 8 mg/hour
Baseline 40 mg
+ 8 mg/hour
80 mg
+ 4 mg/hour
80 mg
+ 8 mg/hour
120 mg
+8 mg/hour
120 mg (2hours)
+ 8 mg/hour
2%
23.3%*
36.7%*
46.7% 46.7% 43.3%
Röhss K, et al. Intl J Clin Pharm Ther 2007;45:345–54
n=25 n=23 n=24 n=24 n=22 n=20
Comparison of acid control
between PPIs;
Which one is the best???
http://www.ncbi.nlm.nih.gov/pubmedhealt
h/PMH0008767/#summary.t1
Esomeprazole
Intragastric pH with high-dose iv PPI
therapy (Eso Vs Panto)
• Clinical pharmacology studies
• H. pylori-negative healthy volunteers
• 24 hour iv infusion
1Röhss K, et al. Intl J Clin Pharm Ther 2007;45:345–54; 2Metz DC, et al. Aliment Pharmacol Ther 2006;23:985–95
n Median/mean Time pH>6
24-hour pH (0–24 hours)
Esomeprazole
80 mg + 8 mg/hour1 25 5.8 12.6
Pantoprazole
80 mg + 8 mg/hour2 36 5.0 5.5–6.7
* This is not “ a head to head” study
Day #1 Day #5
Once-daily dosing with esomeprazole 40 mg i.v. provides
faster and more pronounced intragastric acid control than
pantoprazole 40 mg
Esomeprazole 40 mg IV satu kali sehari lebih cepat dan lebih efektif mengontrol
keasaman lambung dibandingkan pantoprazole 40 mg IV
Rata Rata Lama Pengontrolan pH Intragastric ( Jam )
Esomeprazole i.v 40 mg
Pantoprazole i.v 40 mg
Esomeprazole 40 mg i.v. lebih mampu mempertahankan pH > 4
lebih lama dibandingkan pantoprazole 40 mg i.v
Grafik pH 24-jam intragastrik
Prosentase lama Pengontrolan Asam Lambung selama
monitoring 24 Jam (Eso Vs Lanso)
Esomeprazole 40 mg i.v mempertahankan pH > 4 lebih lama
dibandingkan lansoprazole 30mg i.v.
ESOMEPRAZOLE
pada pencegahan perdarahan ulang ulkus Peptikum
Pasien perdarahan ulkus peptikum yang mengalami perdarahan ulang,
yang diterapi dengan esomeprazol secara signifikan lebih sedikit
dibandingkan plasebo, baik dalam waktu 7 hari ataupun 30 hari
pemberian.
n= 375 n= 389
Esomeprazole beats GERD more than others
 Safety
 Tolerability
 Effectivity
 Cost
 Availability
International Pharmaceutical Society, Council Statement, 2012
 Esomeperazole : Some Drug interactions and side effects
 Initially, there was some worry that PPIs might increase the risk of
developing stomach cancer. Those concerns were unfounded, but
others have taken their place, partly because people often take PPIs
on a daily basis for years, so the total exposure to the drug ends up
being quite significant. Here’s a rundown of the some of the drug
interactions and side effects that are causing concern:
 Interaction with clopidogrel. Clopidogrel (sold as Ceruvin, Clopilet,
and Plavix) is a drug that discourages the formation of artery-
clogging blood clots and is often taken by people with heart disease
to prevent heart attacks and stroke. But clopidogrel has a significant
downside: it’s hard on the lining of the stomach and intestines, so it
increases the risk of gastrointestinal bleeding. To keep those bleeds
from happening, doctors have often prescribed a PPI with
clopidogrel, especially if the patient is also taking aspirin. Like
clopidogrel, aspirin makes blood clots less likely to form, and dual
clopidogrel-aspirin therapy is recommended after placement of an
artery-opening coronary stent. But aspirin, too, is rough on the
gastrointestinal lining.
 The trouble is that PPIs — and omeprazole in particular — inhibit an
enzyme called CYP2C19 that’s crucial to one of the metabolic steps
that activates clopidogrel and its effects. In 2009, the FDA issued a
strong warning that said patients taking clopidogrel should avoid
taking omeprazole (and, secondarily, the related drug Nexium)
because they may cut clopidogrel’s effectiveness in half.
 Fracture risk. Some studies have shown an association between PPIs and the risk of fracture
— particularly hip fracture — while others have not. The FDA decided in 2010 that there was
enough evidence of fracture risk to warrant a warning about it. Calcium is absorbed in the
small intestine, not the stomach. But low stomach acid levels can have downstream effects,
especially in the duodenum, and some research shows that one of them could be reduced
absorption of calcium, which could lead to osteoporosis, weaker bones, and, consequently,
a greater chance of breaking a bone. The fracture risk is probably pretty small, but it’s
another reason for not taking a PPI unless necessary.
 Pneumonia risk. Several studies have shown that people taking PPIs seem to be more likely
to get pneumonia than those who aren’t. The association has been documented among
people living in the community and hospital patients alike. Normally, stomach acid creates a
fairly inhospitable environment for bacteria, but if acid levels are reduced by PPIs, the
bacteria count can go up. The thinking is that in people with GERD who take PPIs, bacteria-
laden stomach contents may travel up the esophagus and then get inhaled into the windpipe
and lungs, where the bacteria cause pneumonia.
 C. difficile risk. People typically develop Clostridium difficile infections in the hospital after
taking antibiotics that have disrupted the natural bacterial ecology of the large intestine.
The infections cause diarrhea but can also become a lot more serious, even life-threatening.
Studies have shown a fairly strong statistical correlation between PPI use and C. difficile
infection, although it’s still just a correlation and not proof of direct cause and effect. Some
experimental evidence suggests that PPIs may change conditions in the gut to be more
favorable to C. difficile bacteria.
 Iron and B12 deficiency. Stomach acid helps render the iron and vitamin B12 from food into
forms that are readily absorbed. So there was worry that an unintended consequence of PPIs
would be deficiencies of this vitamin and mineral because of lower stomach acid levels. But
research has shown that if there is any effect, it’s mild, so those concerns have been
largely allayed.
Terima Kasih
Mohon maaf jika
ada yang kurang
berkenan

More Related Content

What's hot

Peptic ulcer disease, upper gastrointestinal tract bleeding management
Peptic ulcer disease, upper gastrointestinal tract bleeding managementPeptic ulcer disease, upper gastrointestinal tract bleeding management
Peptic ulcer disease, upper gastrointestinal tract bleeding management
Munkhtulga Gantulga
 
Clinical approach to hypertension in the young
Clinical approach to hypertension in the youngClinical approach to hypertension in the young
Clinical approach to hypertension in the young
Sittichai Pinyopodjanard
 
Approach to gastrointestinal bleeding
Approach to gastrointestinal bleedingApproach to gastrointestinal bleeding
Approach to gastrointestinal bleedingSamir Haffar
 
Upper GI bleeding
Upper GI bleedingUpper GI bleeding
Upper GI bleeding
AlsulmiRawan
 
Gi bleeding presentation
Gi bleeding presentationGi bleeding presentation
Gi bleeding presentation
abinash66
 
Heartburn and Acid Reflux: Causes & New Treatment Options
Heartburn and Acid Reflux: Causes & New Treatment OptionsHeartburn and Acid Reflux: Causes & New Treatment Options
Heartburn and Acid Reflux: Causes & New Treatment Options
Affinity Health System
 
Is Proton pump inhibitors (PPIs) the best treatment for Gastroesophageal Refl...
Is Proton pump inhibitors (PPIs) the best treatment for Gastroesophageal Refl...Is Proton pump inhibitors (PPIs) the best treatment for Gastroesophageal Refl...
Is Proton pump inhibitors (PPIs) the best treatment for Gastroesophageal Refl...
Harley Lam Hoi Sun
 
Ascites
AscitesAscites
Ascites
Ed McDonald
 
Acute epigastric pain
Acute epigastric painAcute epigastric pain
Acute epigastric pain
Jwan AlSofi
 
GERD / GASTRO ESOPHAGEAL REFLUX
GERD / GASTRO ESOPHAGEAL REFLUX GERD / GASTRO ESOPHAGEAL REFLUX
GERD / GASTRO ESOPHAGEAL REFLUX
Arun Karmakar
 
Basics of GERD, peptic Ulcer & Gastroparesis
Basics of GERD, peptic Ulcer & GastroparesisBasics of GERD, peptic Ulcer & Gastroparesis
Basics of GERD, peptic Ulcer & Gastroparesis
Ajin Pisharody
 
Approach to abdominal pain
Approach to abdominal pain Approach to abdominal pain
Approach to abdominal pain
Patinya Yutchawit
 
Gastritis- Mr. panneh
Gastritis- Mr. pannehGastritis- Mr. panneh
Gastritis- Mr. panneh
abdou panneh
 
3. ASCITES part 1.pdf
3. ASCITES part 1.pdf3. ASCITES part 1.pdf
3. ASCITES part 1.pdf
Pratap Tiwari
 
Peptic ulcer disease
Peptic ulcer diseasePeptic ulcer disease
Peptic ulcer disease
KavyaHB
 
Gastrinoma. Zollinger-Ellison syndrome
Gastrinoma. Zollinger-Ellison syndromeGastrinoma. Zollinger-Ellison syndrome
Gastrinoma. Zollinger-Ellison syndrome
Eduardo Guzman
 
Dyspepsia
DyspepsiaDyspepsia
Dyspepsia
Abino David
 
Upper Gastro-Intestinal Bleeding
Upper Gastro-Intestinal BleedingUpper Gastro-Intestinal Bleeding
Upper Gastro-Intestinal Bleeding
Abdullah Mamun
 
Intradialytic hypotension & Its Managemnet
 Intradialytic hypotension & Its Managemnet Intradialytic hypotension & Its Managemnet
Intradialytic hypotension & Its Managemnet
Dr Ashutosh Ojha
 
Protein energy malnutrition in CKD
Protein energy malnutrition in CKDProtein energy malnutrition in CKD
Protein energy malnutrition in CKD
أحمد عبد الوهاب الجندي
 

What's hot (20)

Peptic ulcer disease, upper gastrointestinal tract bleeding management
Peptic ulcer disease, upper gastrointestinal tract bleeding managementPeptic ulcer disease, upper gastrointestinal tract bleeding management
Peptic ulcer disease, upper gastrointestinal tract bleeding management
 
Clinical approach to hypertension in the young
Clinical approach to hypertension in the youngClinical approach to hypertension in the young
Clinical approach to hypertension in the young
 
Approach to gastrointestinal bleeding
Approach to gastrointestinal bleedingApproach to gastrointestinal bleeding
Approach to gastrointestinal bleeding
 
Upper GI bleeding
Upper GI bleedingUpper GI bleeding
Upper GI bleeding
 
Gi bleeding presentation
Gi bleeding presentationGi bleeding presentation
Gi bleeding presentation
 
Heartburn and Acid Reflux: Causes & New Treatment Options
Heartburn and Acid Reflux: Causes & New Treatment OptionsHeartburn and Acid Reflux: Causes & New Treatment Options
Heartburn and Acid Reflux: Causes & New Treatment Options
 
Is Proton pump inhibitors (PPIs) the best treatment for Gastroesophageal Refl...
Is Proton pump inhibitors (PPIs) the best treatment for Gastroesophageal Refl...Is Proton pump inhibitors (PPIs) the best treatment for Gastroesophageal Refl...
Is Proton pump inhibitors (PPIs) the best treatment for Gastroesophageal Refl...
 
Ascites
AscitesAscites
Ascites
 
Acute epigastric pain
Acute epigastric painAcute epigastric pain
Acute epigastric pain
 
GERD / GASTRO ESOPHAGEAL REFLUX
GERD / GASTRO ESOPHAGEAL REFLUX GERD / GASTRO ESOPHAGEAL REFLUX
GERD / GASTRO ESOPHAGEAL REFLUX
 
Basics of GERD, peptic Ulcer & Gastroparesis
Basics of GERD, peptic Ulcer & GastroparesisBasics of GERD, peptic Ulcer & Gastroparesis
Basics of GERD, peptic Ulcer & Gastroparesis
 
Approach to abdominal pain
Approach to abdominal pain Approach to abdominal pain
Approach to abdominal pain
 
Gastritis- Mr. panneh
Gastritis- Mr. pannehGastritis- Mr. panneh
Gastritis- Mr. panneh
 
3. ASCITES part 1.pdf
3. ASCITES part 1.pdf3. ASCITES part 1.pdf
3. ASCITES part 1.pdf
 
Peptic ulcer disease
Peptic ulcer diseasePeptic ulcer disease
Peptic ulcer disease
 
Gastrinoma. Zollinger-Ellison syndrome
Gastrinoma. Zollinger-Ellison syndromeGastrinoma. Zollinger-Ellison syndrome
Gastrinoma. Zollinger-Ellison syndrome
 
Dyspepsia
DyspepsiaDyspepsia
Dyspepsia
 
Upper Gastro-Intestinal Bleeding
Upper Gastro-Intestinal BleedingUpper Gastro-Intestinal Bleeding
Upper Gastro-Intestinal Bleeding
 
Intradialytic hypotension & Its Managemnet
 Intradialytic hypotension & Its Managemnet Intradialytic hypotension & Its Managemnet
Intradialytic hypotension & Its Managemnet
 
Protein energy malnutrition in CKD
Protein energy malnutrition in CKDProtein energy malnutrition in CKD
Protein energy malnutrition in CKD
 

Similar to The Role of PPIS Which One is The Best for Acute Upper GI Bleeding?

Acute GI Bleedding .ppt
Acute GI Bleedding .pptAcute GI Bleedding .ppt
Acute GI Bleedding .ppt
DeveshAhir
 
Chitlada upper gi bleeding 2
Chitlada upper gi bleeding 2Chitlada upper gi bleeding 2
Chitlada upper gi bleeding 2Aimmary
 
Approach to patients with upper gi bleeding
Approach to patients with upper gi bleedingApproach to patients with upper gi bleeding
Approach to patients with upper gi bleedingRajesh S
 
Gastro Intestinal Bleeding- Healthcare
Gastro Intestinal Bleeding- HealthcareGastro Intestinal Bleeding- Healthcare
Gastro Intestinal Bleeding- Healthcare
Baijayanti Nath
 
upper G I Bleed (non variceal)
upper G I Bleed (non variceal)upper G I Bleed (non variceal)
upper G I Bleed (non variceal)Juned Khan
 
Upper GI bleeding
Upper GI bleedingUpper GI bleeding
Upper GI bleeding
taem
 
gastrointestinal bleeding
gastrointestinal bleedinggastrointestinal bleeding
gastrointestinal bleeding
Sampurna Das
 
Upper gi bleeding
Upper gi bleeding Upper gi bleeding
Upper gi bleeding drvicky666
 
Approach to a child with hematemesis or melena
Approach to a child with hematemesis or melenaApproach to a child with hematemesis or melena
Approach to a child with hematemesis or melenaAvijeet Mishra
 
Approach to a child with hematemesis or melena
Approach to a child with hematemesis or melenaApproach to a child with hematemesis or melena
Approach to a child with hematemesis or melena
Avijeet Mishra
 
TAEM10:Upper Gi Hemorrhage Ems
TAEM10:Upper Gi Hemorrhage EmsTAEM10:Upper Gi Hemorrhage Ems
TAEM10:Upper Gi Hemorrhage Ems
taem
 
Hematemesis in children-Beyond Infancy
Hematemesis in children-Beyond InfancyHematemesis in children-Beyond Infancy
Hematemesis in children-Beyond Infancydivyaanair
 
Upper git bleeding
Upper git bleedingUpper git bleeding
Upper git bleeding
rahulverma1194
 
GIT BLEEDING.pdf
GIT BLEEDING.pdfGIT BLEEDING.pdf
GIT BLEEDING.pdf
HiraBano
 
3255739dwe43ew234eds34ew96-GI-Bleed-ppt.ppt
3255739dwe43ew234eds34ew96-GI-Bleed-ppt.ppt3255739dwe43ew234eds34ew96-GI-Bleed-ppt.ppt
3255739dwe43ew234eds34ew96-GI-Bleed-ppt.ppt
azeygpch
 
Stevens–johnson syndrome
Stevens–johnson syndromeStevens–johnson syndrome
Stevens–johnson syndrome
Dr. Darayus P. Gazder
 
Acute gi b leed (revised) (p) copy
Acute gi b leed (revised) (p)   copyAcute gi b leed (revised) (p)   copy
Acute gi b leed (revised) (p) copyMahmoud El-saharty
 
Upper Gastrointestinal Bleeding (UGIB) - General Approach
Upper Gastrointestinal Bleeding (UGIB) - General ApproachUpper Gastrointestinal Bleeding (UGIB) - General Approach
Upper Gastrointestinal Bleeding (UGIB) - General Approach
Mohamed Badheeb
 
Acute GI Bleed Management 070212.ppt
Acute GI Bleed Management 070212.pptAcute GI Bleed Management 070212.ppt
Acute GI Bleed Management 070212.ppt
JaimeMagaa4
 

Similar to The Role of PPIS Which One is The Best for Acute Upper GI Bleeding? (20)

Acute GI Bleedding .ppt
Acute GI Bleedding .pptAcute GI Bleedding .ppt
Acute GI Bleedding .ppt
 
Chitlada upper gi bleeding 2
Chitlada upper gi bleeding 2Chitlada upper gi bleeding 2
Chitlada upper gi bleeding 2
 
Approach to patients with upper gi bleeding
Approach to patients with upper gi bleedingApproach to patients with upper gi bleeding
Approach to patients with upper gi bleeding
 
Gastro Intestinal Bleeding- Healthcare
Gastro Intestinal Bleeding- HealthcareGastro Intestinal Bleeding- Healthcare
Gastro Intestinal Bleeding- Healthcare
 
upper G I Bleed (non variceal)
upper G I Bleed (non variceal)upper G I Bleed (non variceal)
upper G I Bleed (non variceal)
 
Upper GI bleeding
Upper GI bleedingUpper GI bleeding
Upper GI bleeding
 
gastrointestinal bleeding
gastrointestinal bleedinggastrointestinal bleeding
gastrointestinal bleeding
 
Upper gi bleeding
Upper gi bleeding Upper gi bleeding
Upper gi bleeding
 
Approach to a child with hematemesis or melena
Approach to a child with hematemesis or melenaApproach to a child with hematemesis or melena
Approach to a child with hematemesis or melena
 
Approach to a child with hematemesis or melena
Approach to a child with hematemesis or melenaApproach to a child with hematemesis or melena
Approach to a child with hematemesis or melena
 
TAEM10:Upper Gi Hemorrhage Ems
TAEM10:Upper Gi Hemorrhage EmsTAEM10:Upper Gi Hemorrhage Ems
TAEM10:Upper Gi Hemorrhage Ems
 
Hematemesis in children-Beyond Infancy
Hematemesis in children-Beyond InfancyHematemesis in children-Beyond Infancy
Hematemesis in children-Beyond Infancy
 
Upper git bleeding
Upper git bleedingUpper git bleeding
Upper git bleeding
 
GIT BLEEDING.pdf
GIT BLEEDING.pdfGIT BLEEDING.pdf
GIT BLEEDING.pdf
 
3255739dwe43ew234eds34ew96-GI-Bleed-ppt.ppt
3255739dwe43ew234eds34ew96-GI-Bleed-ppt.ppt3255739dwe43ew234eds34ew96-GI-Bleed-ppt.ppt
3255739dwe43ew234eds34ew96-GI-Bleed-ppt.ppt
 
Stevens–johnson syndrome
Stevens–johnson syndromeStevens–johnson syndrome
Stevens–johnson syndrome
 
Acute gi b leed (revised) (p) copy
Acute gi b leed (revised) (p)   copyAcute gi b leed (revised) (p)   copy
Acute gi b leed (revised) (p) copy
 
upper gi bleed - lecture 1
 upper gi bleed - lecture 1 upper gi bleed - lecture 1
upper gi bleed - lecture 1
 
Upper Gastrointestinal Bleeding (UGIB) - General Approach
Upper Gastrointestinal Bleeding (UGIB) - General ApproachUpper Gastrointestinal Bleeding (UGIB) - General Approach
Upper Gastrointestinal Bleeding (UGIB) - General Approach
 
Acute GI Bleed Management 070212.ppt
Acute GI Bleed Management 070212.pptAcute GI Bleed Management 070212.ppt
Acute GI Bleed Management 070212.ppt
 

Recently uploaded

Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 

Recently uploaded (20)

Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 

The Role of PPIS Which One is The Best for Acute Upper GI Bleeding?

  • 1. The Role of PPIs in Upper Gastrointestinal Bleeding; Which one is The Best? Mangatas SM Manalu Internal Medicine Department Mayapada Hospital – South Jakarta
  • 2. Definitions • Upper GI bleed – arising from the esophagus, stomach, or proximal duodenum • Mid-intestinal bleed – arising from distal duodenum to ileocecal valve • Lower intestinal bleed – arising from colon/rectum
  • 3.  Upper GI Tract ◦ Proximal to the Ligament of Treitz ◦ 65 - 70% of GI Bleeds  Mid Intestinal GI Tract 2-3 % of GI Bleeds  Lower GI Tract ◦ Distal to the Ligament of Treitz ◦ 25 -30% of GI Bleeds
  • 4.
  • 5. Differential Diagnosis of Upper GI bleeding Esophageal varices Gastric varices Erosive gastritis Mallory Weiss tear Reflux esophagitis Gastric malignancy Vascular malformations Nose bleed Aorto-enteric fistula Gastric ulcer Duodenal ulcer Consider the following
  • 6. Tabel 1. Penyebab Tersering Perdarahan SCBA pada Pasien yang menjalani Endoskopi di Pusat Endoskopi RSCM selama tahun 2001-2005 Konsensus Nasional Perdarahan Saluran Cerna Bagian Atas, PB-PGI, 2012
  • 7.  Initial Assessment and Resuscitation  History and Physical Examination  Assessment of the bleeding source  Differential Diagnosis  Investigations  Management ◦ Conservative ◦ Therapeutic
  • 8.  Airway, Breathing and Circulation  Vital Signs: ◦ Pulse, BP, Temperature, Respiratory Rate  Fluid and Resuscitation Plan ◦ Co-morbidities
  • 9.  RR, HR, and BP can be used to estimate degree of blood loss/hypovolaemia Class I Class II Class III Class IV Volume Loss (ml) 0-750 750-1500 1500-2000 >2000 Loss (%) 0-15 15-30 30-40 >40 RR 14-20 20-30 30-40 >40 HR <100 >100 >120 >140 BP Unchanged Unchanged Reduced Reduced Urine Output (ml/hr) >30 20-30 5-15 Anuric Mental State Restless Anxious Anxious/conf used Confused/ lethargic
  • 10.  Confirm the GI Bleed - Hemoptysis or Hemetemesis ???  Manner of Presentation of a GI Bleed ◦ Hemetemesis ◦ Malena ◦ Hematochezia ◦ Occult Blood loss ◦ Symptoms of Blood loss  Is it only the GI Bleed ??  Assessment of the bleed ◦ Dizziness, Syncope, Chest Pain, SOB
  • 11. Bleeding etiology Leading History Mallory -Weiss tear Multiple Emesis before hematemesis, alcoholism Esophageal ulcer Dysphagia, Odynophagia, GERD, Peptic ulcer Epigastric pain, NSAID or aspirin use Stress gastritis Patient in an ICU, gastrointestinal bleeding occurring after admission, respiratory failure, multiorgan failure Varices, portal gastropathy Alcoholism, Cirrhosis Gastric antral vascular ectasia Renal failure, cirrhosis Malignancy Recent involuntary weight loss, dysphagia, cachexia, early satiety Angiodysplasia Chronic renal failure, hereditary hemorrhagic telangiectasia Aortoenteric fistula Known aortic aneurysm, prior abdominal aortic aneurysm repair
  • 12.  Anticoagulation (warfarin/heparin)  Use of Drugs NSAIDs,Steroids,Bisphosphonates  Similar episodes before  H/o Jaundice in past  H/o Abdominal Surgery  H/o Alcoholism  H/o Smoking or Tobacco abuse  H/o Cocaine abuse
  • 13.  Pt’s Consciousness, Orientation  Pallor, Icterus, Clubbing, Pedal Edema  Lymphadenopathy, JVP  Signs of Liver Failure  Systemic Examination ◦ Abdomen, CVS, RS, CNS
  • 14.  Alopecia, Pallor, Icterus, Fetor Hepaticus, Glossitis, Parotid Swelling  Leukonychia, Clubbing, Palmar Erythema, Dupuytren’s Contracture, Asterexis  Loss of Axillary hair, Spider naevi, Gynaecomastia,  Ascites, Splenomegaly, Caput Medusae  Testicular Atrophy, Loss of Pubic Hair  Pedal Edema
  • 15. Stool color and origin/pace of bleeding • Guaiac positive stool – Occult blood in stool – Does not provide any localizing information – Indicates slow pace, usually low volume bleeding • Melena – Very dark, tarry, pungent stool – Usually suggestive of UGI origin (but can be small intestinal, proximal colon origin if slow pace) • Hematochezia – Spectrum: bright red blood, dark red, maroon – Usually suggestive of colonic origin (but can be UGI origin if brisk pace/large volume)
  • 16.  Major causes  Peptic ulcer disease  Esophageal and gastric varices  Hemorrhagic gastritis  Esophagitis  Duodenitis  Mallory-Weiss tear  Angiodysplasia  Upper gastrointestinal malignancy  Anastomotic ulcers (after bariatric surgery)  Dieulafoy lesion
  • 17.  Minor causes  Gastric antral vascular ectasia (watermelon stomach)  Portal hypertensive gastropathy  Gastric polyps  Aortoenteric fistula  Connective tissue disease  Postprocedural: nasogastric tube erosions, endoscopic biopsy, endoscopic polypectomy, endoscopic sphincterotomy
  • 18.  Complete Blood count, ESR,  Liver and Renal Function Tests, Electrolytes  Prothrombin Time and INR  BUN / Creatinine – ratio > 30 sensitivity of 68% and a specificity of 98%  Stool Occult Blood Test  Grouping and Cross Matching  ECG, Cardiac enzymes(if essential)  HIV, HbsAg, AntiHCV Markers
  • 19.  ABC’s  Fluid Resucitation  NG Tube insertion and Lavage  Hemodynamically Unstable – Hypotension, Tachycardia, Postural Changes Urgent Endoscopy  Hemodynamically Stable  Plan Early Endoscopy  Tranexamic Acid I.V (+ Vit K in Liver Cirrochis)  IV PPI Therapy
  • 20.  A grossly bloody aspirate in the atraumatic NG insertion CONFIRMS a UGI Bleed  The type of bleed  Red blood - active bleeding  Coffee ground - recently active bleeding.  Continued aspiration of red blood - severe, active hemorrhage.  Clears the field for endoscopic visualization  Prevent aspiration of gastric content  However, lavage may not be positive if bleeding has ceased or arises beyond a closed pylorus.
  • 21. An algorithm in the management of acute nonvariceal GI bleeding Acute upper GI bleeding Initial resuscitation, airway, volume restoration, nasogastric tube, empiric high-dose PPI, risk stratification using clinical factors Signs of on-going bleeding; such as shock and fresh hematemesis or hematochezia Urgent endoscopy Stable patient Endoscopy next morning Epinephrine injection + Thermocoagulation to actively bleeding ulcers and ulcers with NBW Clots elevated and treatment to underlying vessel Bleeding stopped Unable to control bleeding, access or localize bleeding point in the presence of massive bleeding. Second re-bleed Consider early discharge Low-risk ulcers; flat pigments and clean base
  • 22. Treatment in Harisson’s PIM (18 th ed-2012) 1. Laine L. Gastrointestinal Bleeding. In Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrisons Princ Intern Med. 18th ed. New York: The McGraw-Hill Companies; 2012.
  • 23.
  • 24.  Age > 60 yrs  Comorbidities (Renal failure, Liver failure, CHF, Malignancy)  Variceal bleeding (as compared with nonvariceal bleeding)  Shock or hypotension on presentation  Increasing number of units of blood transfused  Active bleeding on Endoscopy  Bleeding Ulcer of >2cm or a Spurting vessel  Need for emergency surgery
  • 25. TEST IQ BAGAIMANA CARA MEMBEDAKAN MANA YANG SELEBRITIS dan YANG BUKAN SELEBRITIS (sok selebritis) Dari foto ini???
  • 26.
  • 27. JAWAB: YANG SELEBRITIS TAHU BETUL DI MANA LETAK KAMERA, MELIHAT KE ARAH KAMERA SAAT DIFOTO KARENA SUDAH BIASA BERPOSE, sedangkan Yang SOK SELEBRITIS TIDAK TAHU LETAK KAMERA “JULING”....... LOL...!!...!!....!!!....
  • 28. We Are Focusing on Non Variceal UGI’s Bleeding
  • 29.
  • 31.
  • 33.
  • 34. • PPI Infusion  IV Omeperazole 80mg bolus then 8mg/hr infusion or Esomeprasole 40 mg bolus then 4 mg/hr infusion • Endoscopic Therapy  Bipolar Coagulation, Heater Probe, Injection Therapy(Absolute Alcohol, 1:10,000 epinephrine), Hemoclips  Medical Management  After Acute Phase ◦ Antacids, H2 receptor Antagonists, oral PPIs, ◦ Cytoprotective Agents - Bismuth Preparations, Prostaglandin Analogues ◦ H.Pylori Eradication  Surgical Management ◦ Duodenal Ulcer ◦ Gastric Ulcer
  • 35. Ann Intern Med. 2010;152:101-113.
  • 36. Peran dari obat penekan asam lambung • Terapi farmakologis menggunakan obat yang mampu menekan sekresi asam lambung merupakan pilihan yang paling banyak digunakan sebagai standar pengobatan untuk kasus perdarahan. Termasuk didalamnya untuk pencegahan perdarahan ulang 1-5 • Tujuan terapi pada pasien tersebut adalah mencapai pH dalam lambung (intragastric) diatas 6, sebuah kondisi dimana proses pembentukan bekuan darah dapat stabil 1,6-7 1. Lin H-J, et al. Arch Intern Med 1998; 158: 54-8. 2. Lau JWY, et al. N Eng J Med 2000; 343: 310-6. 3. Liontiadis GI, et al. Aliment Pharmacol ther 2005; 22: 169-74. 4. Sung JJ, et al. Ann Intern Med 2003; 139: 237-43. 5. Barkun A, et al. Gastroenterology 2004; 126: A78 (Abstract). 6. Vorder Bruegge WF, et al. J Clin Gastroenterol 1990; 12: (Suppl 2): S35-40. 7. van Resburg, et al. Am J Gastroenterol 2003; 98: 2635-41
  • 37. Tingkatan pH lambung yang disarankan pada berbagai kasus penyakit asam lambung pH lambung Indikasi 3.5 Penurunan kejadian perdarahan karena stress mukosa lambung 4.5 Pepsin tidak aktif sebagai faktor agresif mukosa lambung =5 99.9% netralisasi asam < 6 Pencegahan koagulasi dan aggregrasi platelet darah  6 Penurunan kejadian perdarahan ulang 8 Penghancuran pepsin Stress- Related Mucosal Disease Prevention of Ulcer Rebleeding Adapted from Vorder Bruegge WF, et al. J Clin Gastroenterol. 1990;12:S35–S40.
  • 38. Stress Related Mucosal Disease perlu pH>3.5 pH lambung Indikasi 3.5 Penurunan kejadian perdarahan karena stress mukosa lambung 4.5 Pepsin tidak aktif sebagai faktor agresif mukosa lambung =5 99.9% netralisasi asam < 6 Pencegahan koagulasi dan aggregrasi platelet darah  6 Penurunan kejadian perdarahan ulang 8 Penghancuran pepsin Stress- Related Mucosal Disease Prevention of Ulcer Rebleeding Adapted from Vorder Bruegge WF, et al. J Clin Gastroenterol. 1990;12:S35–S40.
  • 39. • Stress-related mucosal disease (SRMD) merupakan kondisi berkesinambungan dari kerusakan mukosa (superficial mucosal damage) hingga stress ulcer (focal deep mucosal damage). • Disebabkan iskemi mukosa, SRMD biasanya dilihat pada pasien yang dirawat di Intensive Care Unit (ICU). Stress-related mucosal disease dan pH>3 Multiple ulcers of the stomach, occurring in a chronically debilitated patient.
  • 40. Stress Ulcers & Non Stress Ulcers – perbedaan patofisiologi Stress ulcer Non-stress ulcer (PUD) • Multiple • Acid/pepsin secretory mucosa • Lack of chronic inflammation • Asymptomatic (mostly!) • Usually solitary • Distal stomach/duodenum • Chronic inflammation • Symptomatic
  • 41. Faktor Risiko perdarahan lambung karena Stress Ulcer • Respiratory failure • Coagulopathy • Increased risk with increased severity of illness • Multiple trauma • Age >65 • Corticosteroids • Prolonged NG tube placement • NSAIDs • Major surgery • Respiratory failure • Renal failure • Acute hepatic failure • Multiple organ failure • Alcoholism • Increase IgA antibody to HP • Head injury • Sepsis • Burns >30–35% BSA Curr Med Res Opin. 2005;21(1):11-18.
  • 42. Terapi pada kasus Stress Ulcer Curr Med Res Opin. 2005 Jan;21(1):11–18. • Current preventative treatment strategies o Histamine 2 receptor antagonists (H2RAs) – Suppressing acid secretion o Proton pump inhibitors (PPIs) - Suppressing acid secretion o Sucralfate - provides a protective barrier against acid in the GI tract. • In the past, H2RAs have been preferentially used over PPIs-available in liquid and intravenous formulations. • Currently, PPI are preferable-availability of suspension and IV formulations. Penelitian membuktikan bahwa PPI memberikan efikasi yang lebih baik pada pencegahan stress Ulcer dibandingkan H2RA
  • 43. pH>6 dibutuhkan untuk pencegahan perdarahan berulang pH lambung Indikasi 3.5 Penurunan kejadian perdarahan karena stress mukosa lambung 4.5 Pepsin tidak aktif sebagai faktor agresif mukosa lambung =5 99.9% netralisasi asam < 6 Pencegahan koagulasi dan aggregrasi platelet darah  6 Penurunan kejadian perdarahan ulang 8 Penghancuran pepsin Stress- Related Mucosal Disease Prevention of Ulcer Rebleeding Adapted from Vorder Bruegge WF, et al. J Clin Gastroenterol. 1990;12:S35–S40.
  • 44. pH intragastric >=6 dibutuhkan untuk mencegah disagregasi platelet pada kasus perdarahan gastrointestinal yang diebabkan oleh ulkus Target pH intragastrik pada kasus perdarahan ulkus peptikum Green FW, et al. Gastroenterology 1978;74:38–43
  • 46.
  • 47.
  • 48. Efektivitas PPI dalam menurunkan kejadian perdarahan berulang pada pasien dengan perdarahan non variceal Barkun AN, et al. Ann Intern Med. 2010;152:101-113
  • 49. Percentage of time pH>6 during first 3 hours with esomeprazole iv (healthy volunteers) 0 20 40 60 80 100 Mean fraction of first 3 hours (%) *p<0.05 versus 80 mg + 8 mg/hour Baseline 40 mg + 8 mg/hour 80 mg + 4 mg/hour 80 mg + 8 mg/hour 120 mg +8 mg/hour 120 mg (2hours) + 8 mg/hour 2% 23.3%* 36.7%* 46.7% 46.7% 43.3% Röhss K, et al. Intl J Clin Pharm Ther 2007;45:345–54 n=25 n=23 n=24 n=24 n=22 n=20
  • 50. Comparison of acid control between PPIs; Which one is the best??? http://www.ncbi.nlm.nih.gov/pubmedhealt h/PMH0008767/#summary.t1
  • 51.
  • 53.
  • 54.
  • 55.
  • 56. Intragastric pH with high-dose iv PPI therapy (Eso Vs Panto) • Clinical pharmacology studies • H. pylori-negative healthy volunteers • 24 hour iv infusion 1Röhss K, et al. Intl J Clin Pharm Ther 2007;45:345–54; 2Metz DC, et al. Aliment Pharmacol Ther 2006;23:985–95 n Median/mean Time pH>6 24-hour pH (0–24 hours) Esomeprazole 80 mg + 8 mg/hour1 25 5.8 12.6 Pantoprazole 80 mg + 8 mg/hour2 36 5.0 5.5–6.7 * This is not “ a head to head” study
  • 57. Day #1 Day #5 Once-daily dosing with esomeprazole 40 mg i.v. provides faster and more pronounced intragastric acid control than pantoprazole 40 mg
  • 58. Esomeprazole 40 mg IV satu kali sehari lebih cepat dan lebih efektif mengontrol keasaman lambung dibandingkan pantoprazole 40 mg IV
  • 59. Rata Rata Lama Pengontrolan pH Intragastric ( Jam ) Esomeprazole i.v 40 mg Pantoprazole i.v 40 mg Esomeprazole 40 mg i.v. lebih mampu mempertahankan pH > 4 lebih lama dibandingkan pantoprazole 40 mg i.v Grafik pH 24-jam intragastrik
  • 60.
  • 61. Prosentase lama Pengontrolan Asam Lambung selama monitoring 24 Jam (Eso Vs Lanso) Esomeprazole 40 mg i.v mempertahankan pH > 4 lebih lama dibandingkan lansoprazole 30mg i.v.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66.
  • 67. ESOMEPRAZOLE pada pencegahan perdarahan ulang ulkus Peptikum Pasien perdarahan ulkus peptikum yang mengalami perdarahan ulang, yang diterapi dengan esomeprazol secara signifikan lebih sedikit dibandingkan plasebo, baik dalam waktu 7 hari ataupun 30 hari pemberian. n= 375 n= 389
  • 68.
  • 69.
  • 70. Esomeprazole beats GERD more than others
  • 71.
  • 72.
  • 73.  Safety  Tolerability  Effectivity  Cost  Availability International Pharmaceutical Society, Council Statement, 2012
  • 74.
  • 75.
  • 76.  Esomeperazole : Some Drug interactions and side effects  Initially, there was some worry that PPIs might increase the risk of developing stomach cancer. Those concerns were unfounded, but others have taken their place, partly because people often take PPIs on a daily basis for years, so the total exposure to the drug ends up being quite significant. Here’s a rundown of the some of the drug interactions and side effects that are causing concern:  Interaction with clopidogrel. Clopidogrel (sold as Ceruvin, Clopilet, and Plavix) is a drug that discourages the formation of artery- clogging blood clots and is often taken by people with heart disease to prevent heart attacks and stroke. But clopidogrel has a significant downside: it’s hard on the lining of the stomach and intestines, so it increases the risk of gastrointestinal bleeding. To keep those bleeds from happening, doctors have often prescribed a PPI with clopidogrel, especially if the patient is also taking aspirin. Like clopidogrel, aspirin makes blood clots less likely to form, and dual clopidogrel-aspirin therapy is recommended after placement of an artery-opening coronary stent. But aspirin, too, is rough on the gastrointestinal lining.  The trouble is that PPIs — and omeprazole in particular — inhibit an enzyme called CYP2C19 that’s crucial to one of the metabolic steps that activates clopidogrel and its effects. In 2009, the FDA issued a strong warning that said patients taking clopidogrel should avoid taking omeprazole (and, secondarily, the related drug Nexium) because they may cut clopidogrel’s effectiveness in half.
  • 77.  Fracture risk. Some studies have shown an association between PPIs and the risk of fracture — particularly hip fracture — while others have not. The FDA decided in 2010 that there was enough evidence of fracture risk to warrant a warning about it. Calcium is absorbed in the small intestine, not the stomach. But low stomach acid levels can have downstream effects, especially in the duodenum, and some research shows that one of them could be reduced absorption of calcium, which could lead to osteoporosis, weaker bones, and, consequently, a greater chance of breaking a bone. The fracture risk is probably pretty small, but it’s another reason for not taking a PPI unless necessary.  Pneumonia risk. Several studies have shown that people taking PPIs seem to be more likely to get pneumonia than those who aren’t. The association has been documented among people living in the community and hospital patients alike. Normally, stomach acid creates a fairly inhospitable environment for bacteria, but if acid levels are reduced by PPIs, the bacteria count can go up. The thinking is that in people with GERD who take PPIs, bacteria- laden stomach contents may travel up the esophagus and then get inhaled into the windpipe and lungs, where the bacteria cause pneumonia.  C. difficile risk. People typically develop Clostridium difficile infections in the hospital after taking antibiotics that have disrupted the natural bacterial ecology of the large intestine. The infections cause diarrhea but can also become a lot more serious, even life-threatening. Studies have shown a fairly strong statistical correlation between PPI use and C. difficile infection, although it’s still just a correlation and not proof of direct cause and effect. Some experimental evidence suggests that PPIs may change conditions in the gut to be more favorable to C. difficile bacteria.  Iron and B12 deficiency. Stomach acid helps render the iron and vitamin B12 from food into forms that are readily absorbed. So there was worry that an unintended consequence of PPIs would be deficiencies of this vitamin and mineral because of lower stomach acid levels. But research has shown that if there is any effect, it’s mild, so those concerns have been largely allayed.
  • 78. Terima Kasih Mohon maaf jika ada yang kurang berkenan